BOC Sciences to Reorganize Custom Synthesis for the Pharmaceutical Industry

SHIRLEY, LONG ISLAND CITY, NY, UNITED STATES - Jun 3, 2019 - The New York-based chemical vendor BOC Sciences announces to reorganize its custom synthesis for the pharmaceutical industry.

Synthesis is a series of chemical reactions performed for the purpose of obtaining one or more organic molecules. Chemical synthesis is always an integral part of drug discovery or other chemical processes, so if researchers are to screen numerous potential active ingredients, then chemical synthesis is very necessary. However, this process is no easy task and always challenged by the properties of time-consuming and complexity, which leads to high content of impurities and low yield. Therefore, an efficient custom synthesis of high quality and complex lead compounds is essential in drug development.

“After upgrading and reorganization, the custom synthesis service at BOC Sciences is extended to a greater range, including those very often used for drug developing such as API synthesis, chiral synthesis, radiolabeled chemical synthesis, bioconjugation, process R&D as well as many other types of custom synthesis. Besides, our company is also capable of synthesizing chemicals like nucleosides & nucleotides, carbohydrates, steroids, flavors-fragrance substance, etc.” says Mr. Barron Jones, the Marketing Chief of BOC Sciences. “With concerted efforts from all our lab staff, we are committed to offering our customers worldwide high-quality, high-tech synthesized products and at the same time, maintaining low cost.”

API Synthesis is perhaps the most widely applied type of custom synthesis in the pharmaceutical industry as active pharmaceutical ingredient (API) is the part of a drug product that produces primary therapeutic effects. Sometimes, we need to decide the dosage forms and how more than two active ingredients can be integrated to exert different effects. Chiral synthesis, also known as enantioselective synthesis, has a great importance in the screening of APIs and development of bio or pharmaceutical products. It can be further sub-grouped into chiral ligands, chiral resolution, chiral catalysts, chiral auxiliaries and chiral building blocks.

“Bioconjugation a technique that is generally viewed as an innovation in the pharmaceutical history,” further explains Mr. Jones. “This technique gives a target substance with certain desired properties through the site-specific reaction between the biomolecules and exogenous moieties. Through such covalent linkage approach, a broad range of innovative drug substances or end products are designed, with benefits that have long been desired by researchers, such as improved accuracy of disease diagnosis, enhanced pharmacokinetic properties and treatment efficacy.

The professionals at BOC Sciences will help to develope and optimize clients’ synthetic route in the most cost effective way. Please visit https://www.solutions.bocsci.com/custom-synthesis.htm to know more.

About BOC Sciences

Dedicated to become a trust-worthy brand, BOC Sciences strives to offer strategies and solutions to assist in the resolution of the industry’s most pressing drug development issues. To this end, it provides comprehensive medicinal chemistry services, custom synthesis, analysis/purification, formulation services for pharmaceutical companies engaged in drug discovery and research.